• Post-Doctoral Research Fellow, Genomics and Epidemiology

    Job ID
    Regular Full-Time
    Fred Hutchinson Cancer Research Center
    Biostatistics, Bioinformatics and Computational Biology
  • Overview

    Cures Start Here. At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch’s pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation’s first cancer prevention research program, as well as the clinical coordinating center of the Women’s Health Initiative and the international headquarters of the HIV Vaccine Trials Network. Careers Start Here.

    A postdoctoral research position in molecular epidemiology with focus on multi-omics approaches in ethnically diverse populations is available at the Fred Hutchinson Cancer Research Center. The Hutchinson Center provides a challenging academic and supportive multi-disciplinary research environment.


    We are seeking a recent or prospective doctoral graduate (Ph.D. or equivalent qualification) with a background in Epidemiology and related subject areas. This could include, but is not limited to, training in quantitative genetics, bioinformatics with training in quantitative science, statistical genetics, or a closely related field (please note that this is NOT a laboratory-based position).


    The postdoctoral fellow will work directly with Drs. Charles Kooperberg and Ulrike Peters on analyzing large-scale multi-omics data, including gene expression/RNA sequencing, genotyping/DNA sequencing, methylation and metabolomic data from diverse participants. Participants are enrolled in large cohort studies as well as Biobanks with detailed electronic health record data as part of the Population Architecture using Genomics and Epidemiology (PAGE) consortium and phenotyped for multiple outcomes, including cardiovascular diseases, cancer, type 2 diabetes, blood traits, anthropometric traits and intermediate biomarkers, such as lipids, glucose, insulin or inflammatory markers. The successful applicant will work on multidisciplinary research teams to perform data analyses, develop and/or implement novel statistical methodology, and publish research results. The incumbent will be expected to work independently to complete data analysis. In addition, they will have numerous opportunities to present results at local and PAGE meetings as well as national meetings.


    A Ph.D. or equivalent degree is required with background in epidemiology, quantitative/statistical genetics, bioinformatics or a closely related field. Expertise in computational methods for the analysis of complex, high-dimensional data is desirable, as is a thorough knowledge of high dimensional data resources (such as GTEx, or ENCODE). The position requires a highly motivated individual with excellent written and verbal communication skills.

    Our Commitment to Diversity

    We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We are proud to be an Equal Opportunity and VEVRAA Employer. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. If due to a disability you need assistance/and or a reasonable accommodation during the application or recruiting process, please send a request to our Employee Services Center at escmail@fredhutch.org or by calling 206-667-4700.


    Sorry the Share function is not working properly at this moment. Please refresh the page and try again later.
    Share on your newsfeed